Knee effusion volume assessed by magnetic resonance imaging and progression of knee osteoarthritis: data from the Osteoarthritis Initiative.


Journal

Rheumatology (Oxford, England)
ISSN: 1462-0332
Titre abrégé: Rheumatology (Oxford)
Pays: England
ID NLM: 100883501

Informations de publication

Date de publication:
01 02 2019
Historique:
received: 21 02 2018
pubmed: 12 9 2018
medline: 26 11 2019
entrez: 12 9 2018
Statut: ppublish

Résumé

To examine whether baseline knee joint effusion volume and the change in effusion volume over 1 year are associated with cartilage volume loss, progression of radiographic OA (ROA) over 4 years and risk of total knee replacement over 6 years. This study included 4115 Osteoarthritis Initiative participants with knee joint effusion volume quantified by MRI at baseline. The change in effusion volume over 1 year was assessed. Cartilage volume loss and progression of ROA over 4 years were assessed using MRI and X-ray and total knee replacement over 6 years was assessed. Multiple linear regression and binary logistic regression were used for data analyses. Baseline knee effusion volume (per 5 ml) was positively associated with a loss of medial and lateral cartilage volume [regression coefficient 0.13%/year (95% CI 0.10, 0.17) and 0.13%/year (95% CI 0.10, 0.16), respectively, both P < 0.001], progression of ROA [odds ratio (OR) 1.28 (95% CI 1.20, 1.37), P < 0.001], and risk of knee replacement [OR 1.12 (95% CI 1.05, 1.20), P = 0.001]. A 5 ml increase in knee effusion volume over 1 year was positively associated with medial cartilage volume loss [regression coefficient 0.09%/year (95% CI 0.04, 0.15), P = 0.001], progression of ROA [OR 1.21 (95% CI 1.11, 1.33), P < 0.001] and risk of knee replacement [OR 1.24 (95% CI 1.12, 1.37), P < 0.001]. Knee joint effusion volume assessed from MRI provides a continuous and sensitive measure that was associated with cartilage volume loss, progression of ROA and risk of total knee replacement. It may provide a method to identify individuals with an inflammatory OA phenotype who are at higher risk of disease progression.

Identifiants

pubmed: 30204907
pii: 5094549
doi: 10.1093/rheumatology/key274
pmc: PMC6343462
doi:

Types de publication

Journal Article Multicenter Study Observational Study Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

246-253

Références

J Rheumatol. 2016 Jan;43(1):121-30
pubmed: 26568597
Osteoarthritis Cartilage. 2003 May;11(5):351-60
pubmed: 12744941
IEEE Trans Biomed Eng. 2010 Nov;57(11):
pubmed: 20639173
Osteoarthritis Cartilage. 2018 Feb;26(2):165-174
pubmed: 29224742
Osteoarthritis Cartilage. 2004 Mar;12(3):177-90
pubmed: 14972335
Arthritis Res Ther. 2016 Nov 3;18(1):256
pubmed: 27809891
Arthritis Res Ther. 2017 Feb 2;19(1):18
pubmed: 28148295
BMC Musculoskelet Disord. 2016 Oct 12;17(1):425
pubmed: 27733199
Ann Rheum Dis. 2011 Oct;70(10):1804-9
pubmed: 21791448
Ann Rheum Dis. 2011 Jun;70(6):982-9
pubmed: 21367761
Ann Rheum Dis. 2016 Feb;75(2):390-5
pubmed: 25488799
Ann Rheum Dis. 2016 Mar;75(3):519-25
pubmed: 25550336
Arthritis Res Ther. 2017 Jul 20;19(1):169
pubmed: 28728606
Nat Rev Rheumatol. 2011 Jan;7(1):33-42
pubmed: 21119608
Arthritis Rheum. 1997 Oct;40(10):1856-67
pubmed: 9336422
Ann Rheum Dis. 2016 Jan;75(1):37-44
pubmed: 25589511
Arthritis Rheumatol. 2015 May;67(8):2085-96
pubmed: 25940308
Osteoarthritis Cartilage. 2017 Dec;25(12):1926-1941
pubmed: 28847624
Osteoarthritis Cartilage. 2011 Dec;19(12):1433-9
pubmed: 21930225
Arthritis Rheum. 2011 Oct;63(10):2983-91
pubmed: 21647860
Radiology. 2015 Mar;274(3):810-20
pubmed: 25279436
Osteoarthritis Cartilage. 2008;16 Suppl 3:S8-13
pubmed: 18672386
J Rheumatol. 2014 Jan;41(1):53-9
pubmed: 24293578
Osteoarthritis Cartilage. 2008 Jun;16(6):733-9
pubmed: 18077189
Radiology. 2009 Sep;252(3):772-80
pubmed: 19635831
Arthritis Rheum. 2009 Mar 15;61(3):344-52
pubmed: 19248129
Arthritis Rheum. 2007 May;56(5):1512-20
pubmed: 17469126
JAMA. 2017 May 16;317(19):1967-1975
pubmed: 28510679
J Rheumatol. 2017 Nov;44(11):1644-1651
pubmed: 28864651
N Engl J Med. 2006 Feb 23;354(8):795-808
pubmed: 16495392
Arthritis Rheumatol. 2016 Apr;68(4):837-44
pubmed: 26636246
Arthritis Res Ther. 2010;12(5):R173
pubmed: 20846392

Auteurs

Yuanyuan Wang (Y)

Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.

Andrew J Teichtahl (AJ)

Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.

Jean-Pierre Pelletier (JP)

Osteoarthritis Research Unit, University of Montreal Hospital Research Centre (CRCHUM), Montreal, Quebec, Canada.

François Abram (F)

Medical Imaging Research and Development, ArthroLab Inc., Montreal, Quebec, Canada.

Anita E Wluka (AE)

Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.

Sultana Monira Hussain (SM)

Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.

Johanne Martel-Pelletier (J)

Osteoarthritis Research Unit, University of Montreal Hospital Research Centre (CRCHUM), Montreal, Quebec, Canada.

Flavia M Cicuttini (FM)

Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH